SenesTech Net Income vs. Revenue

SNES Stock  USD 2.14  0.02  0.93%   
Considering the key profitability indicators obtained from SenesTech's historical financial statements, SenesTech may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in February. Profitability indicators assess SenesTech's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2014-12-31
Previous Quarter
-1.6 M
Current Value
-1.3 M
Quarterly Volatility
1.5 M
 
Yuan Drop
 
Covid
At this time, SenesTech's Days Sales Outstanding is comparatively stable compared to the past year. Days Of Sales Outstanding is likely to gain to 97.10 in 2026, whereas Price To Sales Ratio is likely to drop 1.36 in 2026. At this time, SenesTech's Total Other Income Expense Net is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 41.1 K in 2026, whereas Operating Income is likely to drop (7.5 M) in 2026. At this time, SenesTech's Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.51 in 2026, whereas Pretax Profit Margin is likely to drop (3.15) in 2026.
For SenesTech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SenesTech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SenesTech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SenesTech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SenesTech over time as well as its relative position and ranking within its peers.
Check out World Market Map.
For more information on how to buy SenesTech Stock please use our How to Invest in SenesTech guide.The next projected EPS of SenesTech is estimated to be -0.6825 with future projections ranging from a low of -0.6825 to a high of -0.6825. SenesTech's most recent 12-month trailing earnings per share (EPS TTM) is at -2.21. Please be aware that the consensus of earnings estimates for SenesTech is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
SenesTech is projected to generate -0.6825 in earnings per share on the 31st of December 2025. SenesTech earnings estimates show analyst consensus about projected SenesTech EPS (Earning Per Share). It derives the highest and the lowest estimates based on SenesTech's historical volatility. Many public companies, such as SenesTech, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing SenesTech's earnings estimates, investors can diagnose different trends across SenesTech's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SenesTech. If investors know SenesTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SenesTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.21)
Revenue Per Share
1.035
Quarterly Revenue Growth
0.432
Return On Assets
(0.39)
Return On Equity
(0.78)
The market value of SenesTech is measured differently than its book value, which is the value of SenesTech that is recorded on the company's balance sheet. Investors also form their own opinion of SenesTech's value that differs from its market value or its book value, called intrinsic value, which is SenesTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SenesTech's market value can be influenced by many factors that don't directly affect SenesTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SenesTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if SenesTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SenesTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SenesTech Revenue vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining SenesTech's current stock value. Our valuation model uses many indicators to compare SenesTech value to that of its competitors to determine the firm's financial worth.
SenesTech is currently regarded as top stock in net income category among its peers. It also is currently regarded number one company in revenue category among its peers . At this time, SenesTech's Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value SenesTech by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

SenesTech Revenue vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

SenesTech

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(6.18 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

SenesTech

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.86 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

SenesTech Revenue vs Competition

SenesTech is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 2.72 Billion. SenesTech adds roughly 1.86 Million in revenue claiming only tiny portion of equities under Health Care industry.

SenesTech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in SenesTech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, SenesTech will eventually generate negative long term returns. The profitability progress is the general direction of SenesTech's change in net profit over the period of time. It can combine multiple indicators of SenesTech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-7.2 M-7.5 M
Net Loss-7.1 M-7.5 M
Income Before Tax-7.1 M-7.5 M
Total Other Income Expense Net74.8 K78.5 K
Net Loss-11.1 M-11.7 M
Net Loss-7.1 M-7.5 M
Income Tax Expense23.4 K22.2 K
Interest Income50.4 K36.2 K
Net Interest Income39.1 K41.1 K
Non Operating Income Net Other27.6 K26.2 K
Change To Netincome670.5 K637 K
Net Loss(7.97)(8.37)
Income Quality 0.88  0.59 

SenesTech Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on SenesTech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SenesTech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SenesTech's important profitability drivers and their relationship over time.

SenesTech Earnings Estimation Breakdown

The calculation of SenesTech's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of SenesTech is estimated to be -0.6825 with the future projection ranging from a low of -0.6825 to a high of -0.6825. Please be aware that this consensus of annual earnings estimates for SenesTech is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.28
-0.68
Lowest
Expected EPS
-0.6825
-0.68
Highest

SenesTech Earnings Projection Consensus

Suppose the current estimates of SenesTech's value are higher than the current market price of the SenesTech stock. In this case, investors may conclude that SenesTech is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and SenesTech's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
067.51%
-0.28
-0.6825
-2.21

SenesTech Earnings per Share Projection vs Actual

Actual Earning per Share of SenesTech refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering SenesTech predict the company's earnings will be in the future. The higher the earnings per share of SenesTech, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

SenesTech Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as SenesTech, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of SenesTech should always be considered in relation to other companies to make a more educated investment decision.

SenesTech Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact SenesTech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-11
2025-09-30-0.35-0.280.0720 
2025-03-12
2024-12-31-1.5-1.220.2818 
2024-11-12
2024-09-30-3.2-2.071.1335 
2024-08-08
2024-06-30-3.2-3.080.12
2024-05-09
2024-03-31-0.34-0.36-0.02
2024-02-21
2023-12-31-0.44-0.9-0.46104 
2023-11-09
2023-09-30-0.85-0.470.3844 
2023-08-10
2023-06-30-0.78-0.70.0810 
2023-05-11
2023-03-31-0.81-1.32-0.5162 
2023-03-16
2022-12-31-4.2-3.210.9923 
2022-11-14
2022-09-30-4.2-4.4-0.2
2022-08-11
2022-06-30-3.8-4.2-0.410 
2022-05-12
2022-03-31-4.2-3.80.4
2022-03-29
2021-12-31-4.2-4.080.12
2021-11-10
2021-09-30-3.6-3.60.0
2021-08-12
2021-06-30-3-3.00.0
2021-05-13
2021-03-31-3.2-4.4-1.237 
2021-03-25
2020-12-31-10.5-6.63.937 
2020-11-11
2020-09-30-11.8-11.20.6
2020-08-12
2020-06-30-678-11.8666.298 
2020-05-15
2020-03-31-29.2-34.8-5.619 
2020-03-16
2019-12-31-34-41.8-7.822 
2019-11-12
2019-09-30-36-36.00.0
2019-08-13
2019-06-30-40-36.04.010 
2019-05-15
2019-03-31-40-40.00.0
2019-03-28
2018-12-31-38-40.0-2.0
2018-11-12
2018-09-30-44-56.0-12.027 
2018-08-13
2018-06-30-52-100.0-48.092 
2018-05-14
2018-03-31-58-64.0-6.010 
2018-03-29
2017-12-31-78-60.018.023 
2017-11-08
2017-09-30-124-112.012.0
2017-08-10
2017-06-30-112-140.0-28.025 
2017-05-11
2017-03-31-84-136.0-52.061 
2017-03-30
2016-12-31-0.21-8.6-8.393995 

Use SenesTech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SenesTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SenesTech will appreciate offsetting losses from the drop in the long position's value.

SenesTech Pair Trading

SenesTech Pair Trading Analysis

The ability to find closely correlated positions to SenesTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SenesTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SenesTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SenesTech to buy it.
The correlation of SenesTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SenesTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SenesTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SenesTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your SenesTech position

In addition to having SenesTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for SenesTech Stock Analysis

When running SenesTech's price analysis, check to measure SenesTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenesTech is operating at the current time. Most of SenesTech's value examination focuses on studying past and present price action to predict the probability of SenesTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenesTech's price. Additionally, you may evaluate how the addition of SenesTech to your portfolios can decrease your overall portfolio volatility.